ABBOTT has announced a
massive US$230 million investment
in a new “state of the art nutrition
manufacturing facility” in Jiaxing,
China, representing the company’s
biggest ever Chinese investment.
The growing middle class and
over 17 million babies born each
year in China are creating increased
demand for high-quality nutrition
products, with Abbott saying it
anticipates launching a number of
product innovations over the next
three years across the paediatric
nutrition category.The above article was sent to subscribers in Pharmacy Daily's issue from 17 Aug 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Aug 11
STRONG growth in Australia has helped MedAdvisor Solutions achieve robust results for FY24, with a revenue increase of 24.6% on the previous corresponding period to $122.1 million.
WESFARMERS has today reported strong growth in revenue across its Health division and its Australian Pharmaceutical Industries (API) subsidiary, despite a significant reduction in COVID-19 anti-viral product sales.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.